There is an article in New Republic (November 10) by Richard Wurtman, the renowned cancer researcher in which he makes the point that the pursuit of pure science has retarded development of treatment methods and argues that the AIDS crisis, where advocacy groups forced a shift to a more applied focus, hastened drug development. He also argues that applied breakthroughs often drive basic research in fruitful directions. The reverse, he says, is rarely the case Ergo scientists must develop a "new sensibility". The implication of this is that much might be learned by studying why EMDR works as well as whether it does.